Kallyope has a total of 43 patents globally, out of which 1 have been granted. Of these 43 patents, more than 2% patents are active. The United States of America is where Kallyope has filed the maximum number of patents, followed by Pakistan and Taiwan. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Kallyope.
Kallyope was founded in 2015 by Tom Maniatis, Charles Zuker and Richard Axel. Kallyope, Inc. operates as a bio-technology company. The Company focuses on understanding gut-brain biology that will lead to transformational therapeutics to improve human health.
Do read about some of the most popular patents of Kallyope which have been covered by us in this article and also you can find Kallyope patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Kallyope patent portfolio.
How many patents does the Founder and CEO of Kallyope have?
The Founder Tom Maniatis have 2 patent, Charles Zuker have 37 patents, Richard Axel have 109 patents and CEO Jay Galeota has 0 patents.
How many patents does Kallyope have?
Kallyope has a total of 43 patents globally. These patents belong to 12 unique patent families. Out of 43 patents, 36 patents are active.
How Many Patents did Kallyope File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Kallyope Applications Filed | Kallyope Patents Granted |
| 2020 | 22 | – |
| 2021 | 17 | – |
| 2022 | 4 | 1 |
How many Kallyope patents are Alive/Dead?
Worldwide Patents
How Many Patents did Kallyope File in Different Countries?
Countries in which Kallyope Filed Patents
| Country | Patents |
| United States Of America | 6 |
| Pakistan | 5 |
| Taiwan | 5 |
| Uruguay | 5 |
| Argentina | 4 |
| Australia | 2 |
| Canada | 2 |
| Europe | 1 |
| Israel | 1 |
| India | 1 |
| New Zealand | 1 |
Where are Research Centers of Kallyope Patents Located?
What Percentage of Kallyope US Patent Applications were Granted?
Kallyope (Excluding its subsidiaries) has filed 3 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 100%.
Below are the key stats of Kallyope patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Kallyope?
| Law Firm | Total Applications | Success Rate |
| Wilson Sonsini Goodrich & Rosati | 3 | 100% |
List of Kallyope Patent –
| Publication Number | Title |
| US11279702B2 | Ampk Activators |
| US20220226298A1 | Gpr40 Agonists |
| US20220227754A1 | Ampk Activators |
| US20220152164A1 | Gpcr Combination Therapies |
| US20220153719A1 | Gpr119 Agonists |
| US20220002317A1 | Ampk Activators |
| EP3976576A1 | Gpr40 Agonists |
| WO2021263039A1 | Ampk Activators |
| WO2021236617A1 | Ampk Activators |
| WO2021174046A1 | Gpr40 Agonists |
| WO2021174048A1 | Gpr40 Agonists |
| WO2021113362A1 | Sstr5 Antagonists |
| WO2021113368A1 | Sstr5 Antagonists |
| WO2021113363A1 | Sstr5 Antagonists |
| WO2021071837A1 | Gpr119 Agonists |
| WO2020242943A1 | Gpr40 Agonists |
| WO2020197926A1 | Gpcr Combination Therapies |
| AU2020398874A1 | Sstr5 Antagonists |
| AU2020363377A1 | Gpr119 Agonists |
| CA3163243A1 | Sstr5 Antagonists |
| CA3156985A1 | Gpr119 Agonists |
| IL291985D0 | Gpr119 Agonists |
| IN202217025562A | Gpr119 Agonists |
| NZ786879A | Gpr119 Agonists |
| AR121485A1 | Gpr40 Agonists |
| AR121484A1 | Gpr40 Agonists |
| AR120652A1 | Sstr5 Antagonists |
| AR120167A1 | Gpr119 Agonists |
| UY39222A | Ampk Activators |
| UY39106A | Agonists Of Gpr40. |
| UY39107A | Gpr40 Agonists |
| UY38976A | Sstr5 Antagonists |
| UY38908A | Gpr119 Agonists |
| TW202208360A | Ampk Activators |
| TW202140440A | Gpr40 Agonists |
| TW202140424A | Gpr40 Agonists |
| TW202134248A | Sstr5 Antagonists |
| TW202128640A | Gpr119 Agonists |
| PK202100361A0 | Ampk Activators |
| PK202100164A0 | “Gpr40 Agonists” |
| PK202100163A0 | “Gpr40 Agonists” |
| PK202000807A0 | Sstr5 Antagonists |
| PK202000681A0 | “Gpr119 Agonists” |
EXCLUSIVE INSIGHTS COMING SOON!